Status:
COMPLETED
Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients
Lead Sponsor:
Novartis Pharmaceuticals
Conditions:
Renal Transplantation
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
This study will evaluate the safety and efficacy of FTY720 combined with tacrolimus and corticosteroids in patients receiving a kidney transplant
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Completed the 12 month core study
- Informed consent Exclusion Criteria
- N/A Other protocol-defined exclusion criteria may apply.
Exclusion
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT00239876
Start Date
May 1 2005
Last Update
November 2 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.